Company intelligence / Profile preview

Virtus Pharmaceuticals

Newtown, Pennsylvania, United Statesvirtusrx.com ↗

Ownership: Private
Employees: ~32
Development stage: Other

Overview

Virtus Pharmaceuticals is a generic pharmaceutical company that markets a diverse portfolio of products in various therapeutic categories and dosage forms. They have FDA-approved products including Progesterone and Phendimetrazine Tartrate.

Therapeutic areas: Women's HealthEndocrinology
Modalities: Small molecule drugs
Industry: Biotech

Drug pipeline

1 asset

Phendimetrazine

Approved

Partnerships

Linden Capital PartnersWhite Oak Healthcare Finance

Beyond the preview

Go deeper on Virtus Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Virtus Pharmaceuticals.